|10.35||-0.32 / -3.00%|
Data as of 3:59pm ET
|10.35||0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for TG Therapeutics Inc have a median target of 22.00, with a high estimate of 25.00 and a low estimate of 16.00. The median estimate represents a +112.56% increase from the last price of 10.35.
The current consensus among 4 polled investment analysts is to Buy stock in TG Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.